Stocktoria
BioRestorative Therapies, Inc. BRTX
BioRestorative Therapies, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $359,700 | $401,000 | $145,800 | $119,800 | $46,000 | $77,000 | $130,000 | $111,000 | $81,000 | $36,355 |
| Gross profit | $335,856 | $372,928 | $145,800 | — | — | — | — | — | $81,000 | $36,253 |
| R&D expense | $10.1M | $6.7M | $4.0M | $3.5M | $729,058 | $876,829 | $1.7M | $1.5M | $2.2M | $2.9M |
| Operating income | -$15.6M | -$11.6M | -$15.2M | -$19.0M | -$26.3M | -$2.8M | -$8.4M | -$7.6M | -$8.4M | -$7.8M |
| Net income | -$14.2M | -$9.0M | -$10.4M | -$18.5M | -$44.3M | -$11.3M | -$14.6M | -$12.5M | -$9.4M | -$8.6M |
| EPS (diluted) | $-1.58 | $-1.16 | $-2.47 | $-5.11 | — | — | — | — | — | — |
| Operating cash flow | -$10.8M | -$8.2M | -$6.4M | -$5.9M | -$3.3M | -$2.0M | -$6.9M | -$5.1M | -$3.9M | -$5.0M |
| Free cash flow | -$10.9M | -$8.3M | -$6.6M | -$6.2M | -$3.4M | — | -$7.0M | -$5.1M | -$3.9M | -$5.2M |
| Cash & equivalents | $1.5M | $547,890 | $884,377 | $1.7M | $21.0M | — | — | — | — | — |
| Total assets | $4.1M | $12.3M | $12.6M | $16.4M | $22.5M | $4.3M | $1.5M | $1.2M | $1.8M | $1.6M |
| Total liabilities | — | $3.7M | $2.6M | $602,619 | $856,497 | $5.7M | $14.2M | $9.8M | $8.6M | $6.6M |
| Shareholders' equity | $356,744 | $8.5M | $10.0M | $10.3M | $21.6M | -$1.3M | -$12.8M | -$8.6M | -$6.8M | -$5.0M |
Growth · year-over-year · Revenue CAGR 29%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -10.3% | +175.0% | +21.7% | +160.4% | -40.3% | -40.8% | +17.1% | +37.0% | +122.8% | -94.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.